派林生物 (000403.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(派林生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 1,374,813,312.16709,071,800.34260,860,262.392,405,188,425.371,493,472,266.77991,052,056.37500,420,632.99
 营业收入(元) 1,374,813,312.16709,071,800.34260,860,262.392,405,188,425.371,493,472,266.77991,052,056.37500,420,632.99
二、营业总成本(元) 1,033,269,820.34572,349,333.11218,309,593.811,753,334,080.511,106,750,004.93739,455,894.12384,458,625.31
 营业成本(元) 686,742,641.68363,415,906.98134,577,337.571,151,443,270.29751,607,326.54521,570,777.97272,159,168.06
 研发费用(元) 53,761,401.5529,374,532.7614,274,385.6475,364,822.9644,124,749.3425,268,924.6614,574,604.59
 营业税金及附加(元) 11,711,380.566,630,641.452,812,960.9516,795,116.0310,631,122.057,086,073.443,883,278.86
 销售费用(元) 202,257,175.81121,013,394.9341,433,502.19399,568,789.11217,513,216.40128,474,882.5869,820,970.43
 管理费用(元) 121,648,000.2081,307,617.7638,862,602.31165,477,015.71121,745,046.8082,654,030.6436,648,226.79
 财务费用(元) -42,850,779.46-29,392,760.77-13,651,194.85-55,314,933.59-38,871,456.20-25,598,795.17-12,627,623.42
  其中:利息费用(元) 6,195,904.024,473,100.562,457,191.1512,025,699.398,168,032.765,685,755.432,695,047.56
  其中:利息收入(元) 50,319,998.8934,080,972.3616,440,642.5765,179,142.6548,853,571.4431,779,737.1915,472,842.61
三、其他经营收益
 加:公允价值变动收益(元) 8,947,345.725,656,024.042,735,457.884,929,120.512,818,658.86343,428.011,459,166.67
 加:投资收益(元) 4,357,180.642,593,788.88616,694.453,037,839.672,633,361.101,595,637.441,120,250.01
 资产处置收益(元) 12,023.1712,023.17538.03438,082.69437,778.42-8,771.853,815.80
 资产减值损失(元) ---124,406.76---
 信用减值损失(元) 8,065,349.878,969,953.0112,061,663.28-11,816,519.30-4,202,400.69-4,255,949.51-452,725.42
 其他收益(元) 9,710,172.687,409,260.435,208,458.9014,862,220.909,803,391.194,043,535.862,011,260.38
四、营业利润(元) 372,635,563.90161,363,516.7663,173,481.12663,429,496.09398,213,050.72253,314,042.20120,103,775.12
 加:营业外收入(元) 3,283,390.691,075,135.06190.432,515,190.12140,302.82139,864.211.22
 减:营业外支出(元) 5,849,963.673,109,334.41256,781.205,552,547.081,818,009.241,482,014.781,127,236.59
五、利润总额(元) 370,068,990.92159,329,317.4162,916,890.35660,392,139.13396,535,344.30251,971,891.63118,976,539.75
 减:所得税费用(元) 44,255,671.1316,328,318.476,698,573.4372,701,998.9045,990,231.8330,380,479.9112,972,848.55
六、净利润(元) 325,813,319.79143,000,998.9456,218,316.92587,690,140.23350,545,112.47221,591,411.72106,003,691.20
(一)按经营持续性分类
  持续经营净利润(元) 325,813,319.79143,000,998.9456,218,316.92587,690,140.23350,545,112.47221,591,411.72106,003,691.20
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 326,195,419.81143,137,171.5156,376,087.53587,131,491.86349,539,454.75221,005,894.53105,604,403.84
  少数股东损益(元) -382,100.02-136,172.57-157,770.61558,648.371,005,657.72585,517.19399,287.36
 扣除非经常性损益后的净利润(元) 269,739,930.34104,222,388.7236,249,382.73517,574,851.42299,074,323.26191,856,661.4190,018,691.14
七、每股收益
 一、基本每股收益(元) 0.450.200.080.800.480.300.14
 二、稀释每股收益(元) 0.450.200.080.800.480.300.14
八、其他综合收益(元) 20,987.3525,570.44-9,140.3135,642.1576,647.4510,053.725,897.52
 归属于母公司股东的其他综合收益(元) 20,987.3525,570.44-9,140.3135,642.1576,647.4510,053.725,897.52
九、综合收益总额(元) 325,834,307.14143,026,569.3856,209,176.61587,725,782.38350,621,759.92221,601,465.44106,009,588.72
 归属于母公司所有者的综合收益总额(元) 326,216,407.16143,162,741.9556,366,947.22587,167,134.01349,616,102.20221,015,948.25105,610,301.36
 归属于少数股东的综合收益总额(元) -382,100.02-136,172.57-157,770.61558,648.371,005,657.72585,517.19399,287.36
公告日期 2023-10-312023-08-242023-04-292023-04-292022-10-312022-08-302022-04-30
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院